远大住工(02163.HK)续涨19%屡创上市新高 获券商看好
远大住工(02163.HK)承上周五急涨25%再破顶强势,今早逆市进一步升至28.4元上市新高,现造28元,续涨19%,成交261万股,涉资7,046万元。
长沙远大住工是内地建筑工业化开创及领军者,股份去年11月初以每股9.68元来港上市净筹10.73亿元,该公司去年纯利及营收按年升45%及48.5%,至分别达6.77亿及33.69亿元人民币,上市不足半年已宣派末期股息50分人民币。国盛证券最新给予远大住工「买入」评级看37.7元。此外,远大拟申请首次公开发行不超过8,605.4万股A股,於深交所创业板上市,料净筹额约17.97亿人民币用於项目投资及补充流动资金。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.